期刊文献+

双膦酸盐的作用机制和急性时相反应 被引量:13

Mechanisms of action and acute phase responses of bisphosphonates
暂未订购
导出
摘要 双膦酸盐类药物是无机焦磷酸盐人工合成的类似物,对于骨组织具有非凡的选择性。双膦酸盐可分为两种作用模式:不含氮的双膦酸盐通过整合到三膦酸腺苷不可水解的类似物中,引起破骨细胞凋亡;含氮的双膦酸盐通过抑制FPP合酶,使APPPI积累以及抑制蛋白质的异戊稀化,引起破骨细胞凋亡。双膦酸盐能有效抑制骨吸收,减少骨骼相关事件的发生率和恶性肿瘤的骨转移等。同时也发现了一些双膦酸盐的不利影响,其中双膦酸盐引起的急性时相反应,症状普遍见于初始使用的患者中,仅为轻微短暂的流感样症状,包括发热、乏力和肌肉疼痛等,这种非特殊生理性反应与提高了炎症因子的水平有关。本文将详细论述双膦酸盐的作用机制和急性时相反应。 Bisphosphonates are synthetic analogs of inorganic pyrophosphates with high avidity for bone.Bisphosphonates can be classified into two modes of action:non-nitrogen containing bisphosphonates are incorporated into non-hydrolysable analogues of adenosine triphosphate,which induce osteoclast apoptosis;nitrogen-containing bisphosphonates inhibit FPP synthesis which can cause osteoclast apoptosis through two routes,inhibition of protein prenylation and accumulation of Apppl.Bisphosphonates are effective in decreasing bone resorption,the incidence of skeletal related events,and bone metastases of malignant tumors et al.However,adverse effects of bisphosphonates have been observed,which can be associated with acute phase responses generally only occur on first exposure to the drug,an nonspecific physiologic reaction associated with increased levels of inflammatory cytokines,involve only slight transient flu like symptoms including fever,fatigue and myalgia et al.This article will discuss the mechanisms of action and the acute phase responses of bisphosphonates in details.
作者 范靖雪 姜礼红 孟佳 朱秀英 陶天遵 FAN Jingxue JIANG Lihong MENG Jia ZHU Xiuying TAO Tianzun(The 2nd Affiliated Hospital of Harbin Medical University, Harbin 150001, China)
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2016年第9期1216-1220,共5页 Chinese Journal of Osteoporosis
关键词 双膦酸盐 构效关系 作用机制 急性时相反应 Bisphosphonates Structure activity relationships Mechanisms of action Acute phase responses
  • 相关文献

参考文献18

  • 1Russell RGG. Bisphosphonates: The first 40 years[J]. Bone, 2011, 49(1) :2-19.
  • 2曲新华,郝永强.双膦酸盐在骨科相关疾病治疗中的地位及再认识[J].中华骨科杂志,2014,34(1):78-80. 被引量:18
  • 3贾觉睿智,夏维波.双膦酸盐可能降低死亡率[J].中华骨质疏松和骨矿盐疾病杂志,2014,7(2):179-184. 被引量:1
  • 4Schilcher J, Koeppen V, Aspenberg P, et al. Risk of atypical femoral fracture during and after bisphosphonate use [ J ]. New England Journal of Medicine, 2014, 371 (10) : 974-976.
  • 5Roelofs A J, Coxon F P, Ebetino F H, et al. Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monoeytes and localization around osteocytes in vivo. [ J]. Journal of Bone & Mineral Research the Official Journal of the American Society for Bone & Mineral Research, 2010, 25 (3) :606-16.
  • 6Hughes D E, Wright K R, Uy H L, et al. Bisphosphonates promote apoptosls in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10 : 1478 - 1487 [ J]. Journal of Bone & Mineral Research, 2009, 10(10) :1478-87.
  • 7Plotkin L I, Aguirre J I, Kousteni S, et al. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extraeellular signal-regulated kinase activation. [ J]. Journal of Biological Chemistry, 2005,280(8) : 7317-25.
  • 8Rondeau J, Bitsch F, Bourgier E, et al. Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs [ J ]. Chemmedehem, 2006, 1 (2) :267-273.
  • 9Ebetino F H, Hogan A M L, Shuting S, et al. The relationship between the chemistry and biological activity of the bisphosphonates. [ J ]. Bone, 2011, 49 ( 1 ) :20-33.
  • 10Ory S, Brazier H, Pawlak G, et al. Rho GTPases in osteoelasts: Orchestrators of podosome arrangement[J]. European Journal of Cell Biology, 2008, 87(8-9) :469-77.

二级参考文献131

  • 1何贤峰,杨述华,胡勇.双膦酸盐抗骨肿瘤作用的研究进展[J].中国骨肿瘤骨病,2007,6(1):40-43. 被引量:1
  • 2吕靖,马彩玲.绝经后骨质疏松症的治疗新进展[J].医学综述,2007,13(1):62-63. 被引量:38
  • 3中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南.中华骨质疏松和骨矿盐疾病杂志,2011,:1-10.
  • 4Harding AK, W-Dahl A, Geijer M, et al. A single bisphosphonateinfusion does not accelerate fracture healing in high tibial osteoto- mies [J ]. Acta Orthop, 2011, 82(4): 465-470.
  • 5Gong HS, Song CH, Lee YH, et al. Early initiation of bisphospho- nate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures [J]. J Bone Joint Surg Am, 2012, 94(19): 1729-1736.
  • 6Solomon DH, Hochberg MC, Mogun H, et al. The relation be- tween bisphosphonate use and non-union of fractures of the hu- merus in older adults[J]. Osteoporos Int, 2009, 20(6): 895-901.
  • 7Harding AK, Toksvig-Larsen S, Tagil M, et al. A single dose zole- dronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patients[J]. Bone, 2010, 46(3): 649-654.
  • 8Moroni A, Faldini C, Hoang-Kim A, et al. Alendronate improves screw fixation in osteoporotic bone [J]. J Bone Joint Surg Am, 2007, 89(1): 96-101.
  • 9Prieto-Alhambra D, Javaid MK, Judge A, et al. Association be- tween bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective co- hort study[J]. BMJ, 2011, 343: d7222.
  • 10Lin T, Yan SG, Cai XZ, et al. Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 random- ized controlled trials[J]. Osteoporos Int, 2012, 23(6): 1823-1834.

共引文献53

同被引文献169

引证文献13

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部